This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
[P4–575]: ALZ‐801 MECHANISM OF ACTION: STOICHIOMETRY OF BETA AMYLOID ANTI‐OLIGOMER EFFECT, PK/PD, AND CLINICAL DOSE SELECTION FOR CONFIRMATORY PHASE 3 PROGRAM IN ALZHEIMER's DISEASE. (1st July 2017)
Record Type:
Journal Article
Title:
[P4–575]: ALZ‐801 MECHANISM OF ACTION: STOICHIOMETRY OF BETA AMYLOID ANTI‐OLIGOMER EFFECT, PK/PD, AND CLINICAL DOSE SELECTION FOR CONFIRMATORY PHASE 3 PROGRAM IN ALZHEIMER's DISEASE. (1st July 2017)
Main Title:
[P4–575]: ALZ‐801 MECHANISM OF ACTION: STOICHIOMETRY OF BETA AMYLOID ANTI‐OLIGOMER EFFECT, PK/PD, AND CLINICAL DOSE SELECTION FOR CONFIRMATORY PHASE 3 PROGRAM IN ALZHEIMER's DISEASE